An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer
Jing Xu(Hainan University), Congjian Xu(Shanghai Medical College of Fudan University)
Cited by 16
Related Papers
Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells
|Journal of Hematology & Oncology|2014|27
Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells
|Journal of Ovarian Research|2014|23
Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
|Journal of Experimental & Clinical Cancer Research|2014|22
Dicerandrol C Suppresses Proliferation and Induces Apoptosis of HepG2 and Hela Cancer Cells by Inhibiting Wnt/β-Catenin Signaling Pathway
|Marine Drugs|2024|10
Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
|Journal of Experimental & Clinical Cancer Research|2014|3